Eagle Pharmaceuticals
EGRX
$4.16
Share price
-1.89%
Change (1 day)
-85.11%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - P/B ratio
P/B ratio as of April 2024 : 0.2134
According to Eagle Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.2134.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Eagle Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.2695 | -83.46% |
| 2022-12-31 | 1.63 | -56.29% |
| 2021-12-31 | 3.73 | 14.24% |
| 2020-12-31 | 3.26 | -28.62% |
| 2019-12-31 | 4.57 | 31.07% |
| 2018-12-31 | 3.49 | -21.63% |
| 2017-12-31 | 4.45 | -45.2% |
| 2016-12-31 | 8.12 | -47.09% |
| 2015-12-31 | 15.3 | 96.86% |
| 2014-12-31 | 7.80 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 2,299.77% | 🇺🇸 USA |
 Novartis NVS | 4.25 | 1,893.19% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 64.1 | 29,947.62% | 🇺🇸 USA |
 Amgen AMGN | 23.2 | 10,790.59% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 3.09 | 1,346.04% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.16 | 2,320.57% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1.92 | 802.16% | 🇮🇱 Israel |